Product Description
Perhyal rinse. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT05787600?term=BMG0703&draw=2&rank=4)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: University of Milan
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 3: Gingivitis|Tooth, Impacted|Gingival Hemorrhage|Periodontitis|Periodontal Pocket|Gingival Pocket|Periodontal Diseases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
NCT05787600 | P3 |
Completed |
Gingivitis|Periodontal Diseases |
2023-04-20 |
|
Orto_BMG0703_WIS_June_2020 | P3 |
Unknown status |
Tooth, Impacted |
2020-07-01 |
|
BMG0703_ORC_May 2019 v.0 | P3 |
Unknown status |
Gingivitis |
2020-07-01 |
|
Orto_BMG0703_PRD_June_2020 | P3 |
Unknown status |
Gingival Pocket|Periodontal Pocket|Gingival Hemorrhage|Periodontitis |
2020-07-01 |